EC Number |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
---|
2.4.1.212 | -999 |
- |
- |
659171 |
2.4.1.212 | -999 |
- |
activity in wild-type cells and their oncogenic transformants |
659334 |
2.4.1.212 | 0.0000000062 |
- |
HAS activity, HAS1siRNA + HAS2siRNA + HAS3siRNA treatment, plus heregulin |
692996 |
2.4.1.212 | 0.0000000092 |
- |
HAS activity, HAS1siRNA + HAS2siRNA + HAS3siRNA treatment |
692996 |
2.4.1.212 | 0.000000017 |
- |
HAS activity, HAS2siRNA treatment |
692996 |
2.4.1.212 | 0.0000000175 |
- |
HAS activity, HAS1siRNA treatment |
692996 |
2.4.1.212 | 0.0000000188 |
- |
HAS activity, HAS3siRNA treatment |
692996 |
2.4.1.212 | 0.0000000222 |
- |
HAS activity, AG825 treatment |
692996 |
2.4.1.212 | 0.0000000227 |
- |
HAS activity, HAS2siRNA treatment, plus heregulin |
692996 |
2.4.1.212 | 0.000000023 |
- |
HAS activity, thiazolidinedione treatment |
692996 |